NEW YORK (GenomeWeb) – The National Cancer Institute announced that it intends to provide up to $37.8 million in funding over the next three fiscal years to support the Cancer Systems Biology Consortium (CSBC), a network of research centers focused on building predictive models of cancer initiation, progression, and metastasis.

Through a related funding opportunity, the agency has also earmarked $2.1 million over the next two years for a center that will coordinate the activities of CSBC member organizations.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.

Sponsored by

In these times of economic constraint and increasing research costs, shared resource cores have become a cost-effective and essential platform for researchers who seek to investigate complex translational research questions.